Concomitant with endothelial bradykinin B2 receptor dysfunction, systemic levels of the bradykinin-generating enzyme kallikrein as measured by urinary kallikrein are reduced in preeclampsia [85,86,87]. This evidence concerns the gene KLK4 and preeclampsia.